Welcome! You have reached the homepage for the laboratory of Dr. Bryan Heit. Our lab is part of the Department of Microbiology and Immunology at Western University, and we are members of the Center for Human Immunology, the lead centre for the CIHR Human Immunology Network.
Our interests surround the function of phagocytes – white blood cells which ingest (phagocytose) pathogens, particles, and dead cells. We focus on the cellular and molecular processes which control the function of these cells during the maintenance of homeostasis, infection and chronic inflammatory disease. Central to most of our studies is the study of efferoctyosis – the phagocytic removal of apoptotic (dying) cells, and how failures in this process lead to inflammation, autoimmunity and infection.
Phagocytes are a class of white blood cells which have the capacity to engulf large particles such as bacterial and fungal pathogens, and subsequently destroy the engulfed material. The term phagocyte literally translates to “cell that eats”, which is an apt description of the primary function of these cells in our bodies. While there are many types of phagocytes, the Heit lab focuses primarily on macrophages, which play key roles in both maintaining our bodies and in fighting infections.
The Heit lab is excited to announce the publication of our newest paper, a review on how neutrophil granules contribute to the potent antimicrobial capabilities of neutrophils.
— Bryan Heit (@BryanHeit) November 29, 2017
A free read-only full text version of the paper can be found here.
Subscribers to Cell and Tissue Research can get a downloadable copy here.
We are happy to have published two new papers with our collaborators over the past two weeks.
The first paper was published with our collaborators Dr. Warren Lee and Dr. Greg Fairn, both from the St. Michael’s Hospital in Toronto, where we identified the mechanisms mediating the transport of HDL (good cholesterol) into the brain. Unlike other vascular beds in the body, which allow HDL to slowly “leak” into tissues, the vasculature of the brain is very tight, and materials must be actively transported across. We discovered that the scavenger receptor SR-BI binds to HDL in the blood and then transports the HDL across the blood-brain barrier via a process termed “transcytosis”, in which the cells lining the blood vessels shuttle material from the blood-side to the brain-side inside of small intracellular vesicles. More details can be found in our paper, available free at this link.
The second paper was published with our collaborator Dr. Dawn Bowdish at McMaster University. This study investigated the recent (hominid) evolution of the phagocytic receptor MARCO which is required for the destruction of many pathogens via phagocytosis. This study demonstrated that MARCO has undergone recent evolution, with some of the newly occurring mutations enhancing the bacteria-clearing capabilities of MARCO. Additional details can be found in the paper, available at this link.
— Bryan Heit (@BryanHeit) October 26, 2017
We are excited to announce that Charles Yin has won a prestigious Vanier Canada Graduate Scholarship, Canada’s most prestigious scholarship for doctoral students. Charles is a MD/PhD student in the Heit lab, and was 1 of 55 students selected by the CIHR for this award. The Vanier award was established by the Government of Canada “to strengthen Canada’s ability to attract and retain world-class doctoral students and establish Canada as a global centre of excellence in research and higher learning. Vanier Scholars demonstrate leadership skills and a high standard of scholarly achievement in graduate studies in the social sciences and/or humanities, natural sciences and/or engineering and health”.
Charles is spearheading our work into the role of Rab17 during efferocytosis – the removal of dying cells from our tissues. This work has revealed a pathway used by immune cells to avoid unwanted immune responses following normal “housecleaning” of our tissues. Charles has published this research over two papers (publication #1, publication #2).
Charles is also spearheading a collaborative study into macrophage dysfunction during atherosclerotic disease, using macrophages isolated from human heart tissue. We hope that this work will provide insight into heart disease and identify future treatments.
For more information, see Charles’s biography at the Schulich School for Medicine and Dentistry.